048410 — Hyundai Bioscience Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Hyundai Bioscience Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,055	19,215	22,199	18,732	11,812
Net Total Accounts Receivable
Net Total Receivables	19,403	17,264	8,913	1,740	553
Total Inventory
Prepaid Expenses
Total Current Assets	33,269	41,860	34,851	24,012	15,163
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,196	6,674	6,073	6,376	2,904
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	63,236	93,741	80,528	67,327	52,792
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,947	8,968	16,652	8,384	6,947
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	16,246	41,403	18,957	9,091	7,521
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	46,990	52,338	61,571	58,235	45,271
Total Liabilities & Shareholders' Equity	63,236	93,741	80,528	67,327	52,792
Total Common Shares Outstanding